Industry Insights

AI is everywhere in life sciences right now. Promises of speed, efficiency, and breakthrough insights are colliding with genuine concerns about risk, compliance, and long-term impact. This guide is designed to help R&D, IT, and operations leaders cut through the noise and approach AI in early discovery with clearer judgment, grounded expectations, and fewer blind spots.

The real risk isn’t the Vault CRM migration itself but waiting too long to plan. As timelines compress, teams often lose flexibility over scope, sequencing, and how the work unfolds.

You can’t build a next-gen pharma company on a shaky foundation. Here’s what it really takes to get AI-ready and why the backbone of your data systems, not your algorithms, is the place to start.

A Center of Excellence (CoE) is no longer a “nice to have”, it’s the operating model that keeps Veeva programs sustainable and scalable.

Future CRM systems need to integrate more aspects of the customer experience by orchestrating omnichannel engagement, capturing real-time insights, and supporting personalized, compliant interactions across the customer journey.

Approval is approaching, and excitement builds across the organization. Years of research and regulatory work have led to this point, but as the finish line nears, a familiar question surfaces: are we truly ready to go live?

It usually starts with the right intentions. A pre-commercial pharma team is preparing for launch: scoping out field operations, making CRM decisions, and beginning to think about analytics. Everyone is focused on execution. But beneath all of that activity, one critical question gets overlooked: Is your data infrastructure ready to support what’s coming?

What if your CRM could drive smarter, more connected HCP engagement? It starts by rethinking CRM as a Customer Experience Management (CxM) platform—not just a system of record.

For pharma Sales Ops and IT leaders, the biggest drain on ROI isn’t the technology itself — it’s how effectively the field learns to use it.

The email usually arrives on a Monday morning, bringing yet another urgent RFP, a dozen stakeholders, and no time to spare. You pull together what you can, gathering input from R&D, legal, and commercial teams, each requiring additional information.